EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The CONDUCT-AF Trial: Rationale and Design of a Prospective, Randomized, Multicentre Study Comparing Conduction System and Biventricular Pacing in Patients Undergoing Atrioventricular Node Ablation for Heart Failure with Atrial Fibrillation

Maja Ivanovski, Miha Mrak, Anja Zupan Mežnar, Matevž Jan, Catalin Pestrea, Sandro Brusich, Peter Bogyi, Sebastiaan Dhont, Zrinka Jurišić, Vassil Traykov, Borka Pezo Nikolić, Wilfried Mullens und 1 weitere

European Journal of Heart Failure · 2025

DOI: 10.1002/ejhf.70013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Heart Failure, 2025. Verfasst von Maja Ivanovski und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, University Medical Centre Ljubljana, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Failure, Atrioventricular Node, Catheter Ablation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

There is a lack of data from randomized clinical trials comparing treatment outcomes between conduction system pacing (CSP) modalities and biventricular pacing (BVP) in symptomatic patients with refractory atrial fibrillation (AF) scheduled for atrioventricular node ablation (AVNA). The CONDUCT-AF investigates whether CSP is non-inferior to BVP in improving left ventricular ejection fraction (LVEF) and clinical outcomes in heart failure (HF) patients with symptomatic AF undergoing AVNA.

Methods

This study is an investigator-initiated, prospective, randomized, multicentre clinical trial conducted across 10 European centres, enrolling 82 patients with symptomatic AF, HF with reduced LVEF, and narrow QRS. Participants will be randomized 1:1 to CSP or BVP with subsequent AVNA and followed for at least 24 months. The primary endpoint is the change in LVEF after 6 months. Secondary endpoints will include time to the first occurrence of worsening HF or cardiovascular death and its individual components, total number of HF hospitalizations, change in quality of life, N-terminal pro-B-type natriuretic peptide, 6-min walk test distance, and safety outcomes.

Conclusions

The CONDUCT-AF trial will provide critical insights into the optimal pacing modality for patients with HF and refractory AF undergoing AVNA. Recruitment is expected to conclude in 2025, with the first study results anticipated in 2026.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHeart FailureAtrioventricular NodeCatheter AblationCardiac Resynchronization TherapyHeart Conduction SystemHumansProspective StudiesStroke VolumeMaleRandomized Controlled Trials as TopicVentricular Function, LeftMulticenter Studies as TopicFemaleTreatment OutcomeQuality of LifeMiddle AgedAged

Stichwörter der Autor:innen

Atrial fibrillationAtrioventricular node ablationBiventricular pacingConduction system pacingHeart failure

Autor:innen und Institutionen

  • Cardiology Department, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia.
  • Department of Cardiovascular Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Department of Interventional Cardiology, Brasov County Emergency Clinical Hospital, Brasov, Romania.
  • Clinic for Cardiovascular Diseases, Clinical Hospital Centre Rijeka, Rijeka, Croatia.
  • University of Rijeka, Department of Internal Medicine, Medical Faculty, Rijeka, Croatia.

ORCID-Profile: David Žižek

Zitieren

APA

Ivanovski, M., Mrak, M., Mežnar, A. Z., Jan, M., Pestrea, C., Brusich, S., Bogyi, P., Dhont, S., Jurišić, Z., Traykov, V., Nikolić, B. P., Mullens, W., & Žižek, D. (2025). The CONDUCT-AF Trial: Rationale and Design of a Prospective, Randomized, Multicentre Study Comparing Conduction System and Biventricular Pacing in Patients Undergoing Atrioventricular Node Ablation for Heart Failure with Atrial Fibrillation. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.70013

Vancouver

Ivanovski M, Mrak M, Mežnar AZ, Jan M, Pestrea C, Brusich S, et al. The CONDUCT-AF Trial: Rationale and Design of a Prospective, Randomized, Multicentre Study Comparing Conduction System and Biventricular Pacing in Patients Undergoing Atrioventricular Node Ablation for Heart Failure with Atrial Fibrillation. European Journal of Heart Failure. 2025. doi:10.1002/ejhf.70013

BibTeX
@article{Ivanovski2025,
  author = {Ivanovski, Maja and Mrak, Miha and Mežnar, Anja Zupan and Jan, Matevž and Pestrea, Catalin and Brusich, Sandro and Bogyi, Peter and Dhont, Sebastiaan and Jurišić, Zrinka and Traykov, Vassil and Nikolić, Borka Pezo and Mullens, Wilfried and Žižek, David},
  title = {The CONDUCT-AF Trial: Rationale and Design of a Prospective, Randomized, Multicentre Study Comparing Conduction System and Biventricular Pacing in Patients Undergoing Atrioventricular Node Ablation for Heart Failure with Atrial Fibrillation},
  journal = {European Journal of Heart Failure},
  year = {2025},
  doi = {10.1002/ejhf.70013}
}
Kostenlos starten →